Systemic lupus erythematosus presenting with atypical hemolytic uremic syndrome: a case report and review of the literature

Moake JL (2002) Thrombotic microangiopathies. N Engl J Med 347(8):589–600. https://doi.org/10.1056/NEJMra020528

Article  CAS  PubMed  Google Scholar 

Ruggenenti P, Noris M, Remuzzi G (2001) Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Kidney Int 60(3):831–846. https://doi.org/10.1046/j.1523-1755.2001.060003831.x

Article  CAS  PubMed  Google Scholar 

Magil AB, McFadden D, Rae A (1986) Lupus glomerulonephritis with thrombotic microangiopathy. Hum Pathol 17(2):192–194. https://doi.org/10.1016/S0046-8177(86)80293-3

Article  CAS  PubMed  Google Scholar 

Tsao C-H, Hsueh S, Huang J-L (2002) Initial presentation of hemolytic uremic syndrome in a boy with systemic lupus erythematosus. Rheumatol Int 21(4):161–164. https://doi.org/10.1007/s00296-001-0153-z

Article  PubMed  Google Scholar 

Kawasaki Y, Suzuki J, Nozawa R, Suzuki S, Suzuki H (2002) A 12-year-old girl with hemolytic uremic syndrome as initial symptom of systemic lupus erythematosus and a literature review. Am J Nephrol 22(5–6):576–580. https://doi.org/10.1159/000065286

Article  CAS  PubMed  Google Scholar 

Rabbani, M. A., Ahmad, B., Mekan, S. F., Muzaffar, S., & Ali, S. S. (2005). Systemic lupus erythematosus presenting as hemolytic uremic syndrome: A case report. JPMA. The Journal of the Pakistan Medical Association, 55(2), 84–87.

Leban N, Aloui S, Touati D, Lakhdhar R, Skhiri H, Lefranc G, Achour A, Elmay M, López-Trascasa M, Sanchez-Corral P, Chibani J, Khelil A (2010) Atypical hemolytic uremic syndrome in the Tunisian population. Int Urol Nephrol 43:559–564. https://doi.org/10.1007/s11255-010-9754-3

Article  PubMed  Google Scholar 

Samson M, Audia S, Leguy V, Berthier S, Janikashvili N, Martin L, Bonnotte B, Lorcerie B (2012) Haemolytic-uraemic syndrome during severe lupus nephritis: Efficacy of plasma exchange. Intern Med J 42(1):95–98. https://doi.org/10.1111/j.1445-5994.2011.02591.x

Article  CAS  PubMed  Google Scholar 

Hunt BJ, Tueger S, Pattison J, Cavenagh J, D’Cruz DP (2007) Microangiopathic haemolytic anaemia secondary to lupus nephritis: An important differential diagnosis of thrombotic thrombocytopenic purpura. Lupus 16(5):358–362. https://doi.org/10.1177/0961203307077151

Article  CAS  PubMed  Google Scholar 

Taktak, A., Köksoy, A., Başaran, Ö., Kiremitçi, S., Acar, B., Uncu, N., & Çakar, N. (2016). An unexpected diagnostic course of systemic lupus erythematosus. The Turkish Journal of Pediatrics, 58(2), 223–226. https://doi.org/10.24953/turkjped.2016.02.018

Kello N, Khoury LE, Marder G, Furie R, Zapantis E, Horowitz DL (2019) Secondary thrombotic microangiopathy in systemic lupus erythematosus and antiphospholipid syndrome, the role of complement and use of eculizumab: Case series and review of literature. Semin Arthritis Rheum 49(1):74–83. https://doi.org/10.1016/j.semarthrit.2018.11.005

Article  CAS  PubMed  Google Scholar 

Ogawa T, Arai H, Maruyama K, Watanabe T, Kobayashi Y, Kikuchi O, Morikawa A (2000) Association of systemic lupus erythematosus and hemolytic uremic syndrome in a child. Pediatric Nephrology (Berlin, Germany) 14(1):62–64. https://doi.org/10.1007/s004670050016

Article  CAS  PubMed  Google Scholar 

Al Shohaib S, Karsou S, Al Ghamdi S (2000) Hemolytic-uremic syndrome superimposed on chronic lupus nephritis. Nephron 86(3):380. https://doi.org/10.1159/000045811

Article  CAS  PubMed  Google Scholar 

Attar RZ, Ramel EI, Safdar OY, Desoky S (2018) A case of patient with renal lupus with an initial presentation of hemolytic uremic syndrome triggered by streptococcal infection. Clin Case Rep 6(4):712–718. https://doi.org/10.1002/ccr3.1425

Article  PubMed  PubMed Central  Google Scholar 

Park MH, Caselman N, Ulmer S, Weitz IC (2018) Complement-mediated thrombotic microangiopathy associated with lupus nephritis. Blood Adv 2(16):2090–2094. https://doi.org/10.1182/bloodadvances.2018019596

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ono M, Ohashi N, Namikawa A, Katahashi N, Ishigaki S, Tsuji N, Isobe S, Iwakura T, Sakao Y, Tsuji T, Kato A, Fujigaki Y, Shimizu A, Yasuda H (2018) A rare case of lupus nephritis presenting as thrombotic microangiopathy with diffuse pseudotubulization possibly caused by atypical hemolytic uremic syndrome. Internal Med (Tokyo, Japan) 57(11):1617–1623. https://doi.org/10.2169/internalmedicine.0228-17

Article  CAS  Google Scholar 

de Holanda, M. I., Pôrto, L. C., Wagner, T., Christiani, L. F., & Palma, L. M. P. (2017). Use of eculizumab in a systemic lupus erythemathosus patient presenting thrombotic microangiopathy and heterozygous deletion in CFHR1-CFHR3. A case report and systematic review. Clinical Rheumatology, 36(12), 2859–2867. https://doi.org/10.1007/s10067-017-3823-2

Wig S, Chan M, Thachil J, Bruce I, Barnes T (2016) A case of relapsing and refractory catastrophic anti-phospholipid syndrome successfully managed with eculizumab, a complement 5 inhibitor. Rheumatology (Oxford) 55(2):382–384. https://doi.org/10.1093/rheumatology/kev371

Article  PubMed  Google Scholar 

Raufi AG, Scott S, Darwish O, Harley K, Kahlon K, Desai S, Lu Y, Tran M-H (2016) Atypical Hemolytic Uremic Syndrome Secondary to Lupus Nephritis. Responsive Eculizumab Hematol Rep 8(3):6625. https://doi.org/10.4081/hr.2016.6625

Article  PubMed  Google Scholar 

El-Husseini A, Hannan S, Awad A, Jennings S, Cornea V, Sawaya BP (2015) Thrombotic microangiopathy in systemic lupus erythematosus: Efficacy of eculizumab. Am J Kidney Dis 65(1):127–130. https://doi.org/10.1053/j.ajkd.2014.07.031

Article  CAS  PubMed  Google Scholar 

Kronbichler A, Frank R, Kirschfink M, Szilágyi Á, Csuka D, Prohászka Z, Schratzberger P, Lhotta K, Mayer G (2014) Efficacy of eculizumab in a patient with immunoadsorption-dependent catastrophic antiphospholipid syndrome: a case report. Medicine 93(26):e143. https://doi.org/10.1097/MD.0000000000000143

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shapira I, Andrade D, Allen SL, Salmon JE (2012) Brief report: Induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab. Arthritis Rheum 64(8):2719–2723. https://doi.org/10.1002/art.34440

Article  CAS  PubMed  Google Scholar 

Coppo R, Peruzzi L, Amore A, Martino S, Vergano L, Lastauka I, Schieppati A, Noris M, Tovo PA, Remuzzi G (2015) Dramatic effects of eculizumab in a child with diffuse proliferative lupus nephritis resistant to conventional therapy. Pediatric Nephrol (Berlin, Germany) 30(1):167–172. https://doi.org/10.1007/s00467-014-2944-y

Article  Google Scholar 

Pickering MC, Ismajli M, Condon MB, McKenna N, Hall AE, Lightstone L, Terence Cook H, Cairns TD (2015) Eculizumab as rescue therapy in severe resistant lupus nephritis. Rheumatology (Oxford) 54(12):2286–2288. https://doi.org/10.1093/rheumatology/kev307

Article  PubMed  Google Scholar 

Bermea RS, Sharma N, Cohen K, Liarski VM (2016) Use of Eculizumab in Atypical Hemolytic Uremic Syndrome, Complicating Systemic Lupus Erythematosus. J Clin Rheumatol 22(6):320–323. https://doi.org/10.1097/RHU.0000000000000423

Article  PubMed  Google Scholar 

AlGhobaishi, A., Mousa, A. H., Alshaltoni, R. S., Mohsen, A. S., Baothman, A., Adem, H., Eisa, Y., Amin, A., & Edrees, B. (2022). Two concomitant thrombotic microangiopathies in the background of systemic lupus erythematosus: A case report. Annals of Medicine and Surgery (2012), 81, 104541. https://doi.org/10.1016/j.amsu.2022.104541

Alhamoud I, Freiberg SA (2022) Successful discontinuation of eculizumab in a pediatric patient with atypical hemolytic uremic syndrome and underlying systematic lupus erythematosus. Cureus 14(5):e25117. https://doi.org/10.7759/cureus.25117

Article  PubMed  PubMed Central  Google Scholar 

Blum D, Blake G (2015) Lupus-associated thrombotic thrombocytopenic purpura-like microangiopathy. World J Nephrol 4(5):528–531. https://doi.org/10.5527/wjn.v4.i5.528

Article  PubMed  PubMed Central  Google Scholar 

Kim MJ, Lee H, Kim YH, Jin SY, Kim H-J, Oh D, Jeon JS (2021) Eculizumab therapy on a patient with co-existent lupus nephritis and C3 mutation-related atypical haemolytic uremic syndrome: a case report. BMC Nephrol 22(1):86. https://doi.org/10.1186/s12882-021-02293-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Su C-F, Liao H-T, Tsai C-Y (2021) WT1 gene mutations in systemic lupus erythematosus with atypical haemolytic uremic syndrome. Rheumatology (Oxford) 60(3):e81–e82. https://doi.org/10.1093/rheumatology/keaa474

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif